"Traumatic brain injury causes the release of powerful enzymes, especially cathepsin B, which kill neurons, activate inflammation and break down the blood vascular wall. These pathologies can cause behavioral and cognitive dysfunction in the patient."
ALSP's therapeutic approach is to chemically inhibit the enzynes and thereby prevent the pathology.
